Core Laboratories (NYSE:CLB) Shares Gap Down - Here's Why

Key Points

• Shares gapped down about 4.3%, opening at $16.05 after a $16.87 close and last traded near $16.41 on volume of ~116,519 shares.
• Core Laboratories beat quarterly estimates with $0.21 EPS (vs. $0.20) and $138.26M revenue (vs. $130.4M), with revenue up 7% year-over-year and Q1 2026 guidance of $0.110–0.150 EPS.
• The stock carries a consensus "Hold" rating from analysts (four analysts) with a consensus target price of $12.50, and Weiss Ratings reaffirmed a "hold (c)" rating.

Shares of Core Laboratories Inc. (NYSE:CLB - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $16.87, but opened at $16.05. Core Laboratories shares last traded at $16.4070, with a volume of 116,519 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Core Laboratories in a report on Monday, December 29th. Four equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $12.50.

Core Laboratories Stock Down 4.3%

The company has a market capitalization of $752.04 million, a PE ratio of 24.13, a P/E/G ratio of 14.14 and a beta of 1.10. The stock's fifty day moving average is $18.04 and its two-hundred day moving average is $15.88. The company has a current ratio of 2.07, a quick ratio of 1.57 and a debt-to-equity ratio of 0.39.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.20 by $0.01. The business had revenue of $138.26 million during the quarter, compared to the consensus estimate of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.09%. The firm's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.22 earnings per share. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. As a group, analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 9th. Investors of record on Monday, February 16th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, February 13th. Core Laboratories's payout ratio is 5.97%.

Institutional Trading of Core Laboratories

A number of large investors have recently bought and sold shares of CLB. Ariel Investments LLC lifted its position in shares of Core Laboratories by 25.5% during the 2nd quarter. Ariel Investments LLC now owns 12,976,463 shares of the oil and gas company's stock valued at $149,489,000 after buying an additional 2,634,438 shares during the last quarter. CWA Asset Management Group LLC purchased a new stake in Core Laboratories during the fourth quarter valued at about $9,978,000. Goldman Sachs Group Inc. boosted its position in Core Laboratories by 185.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 845,251 shares of the oil and gas company's stock worth $13,549,000 after purchasing an additional 548,657 shares during the period. Disciplined Growth Investors Inc. MN boosted its position in Core Laboratories by 9.7% during the third quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company's stock worth $73,787,000 after purchasing an additional 528,976 shares during the period. Finally, MAC Alpha Capital Management LP purchased a new position in shares of Core Laboratories in the fourth quarter worth about $5,016,000. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company's portfolio spans two primary service lines: reservoir description and production enhancement.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.